| Literature DB >> 32344878 |
Mathilde Bouteiller1,2, Mathias Gallique1,3,4, Yvann Bourigault1,2, Artemis Kosta5, Julie Hardouin6,7, Sebastien Massier6,7, Yoan Konto-Ghiorghi1, Corinne Barbey1,2, Xavier Latour1,2, Andréa Chane1,2, Marc Feuilloley1, Annabelle Merieau1,2.
Abstract
Type VI secretion systems (T6SSs) are contractile bacterial multiprotein nanomachines that enable the injection of toxic effectors into prey cells. The Pseudomonas fluorescens MFE01 strain has T6SS antibacterial activity and can immobilise competitive bacteria through the T6SS. Hcp1 (hemolysin co-regulated protein 1), a constituent of the T6SS inner tube, is involved in such prey cell inhibition of motility. Paradoxically, disruption of the hcp1 or T6SS contractile tail tssC genes results in the loss of the mucoid and motile phenotypes in MFE01. Here, we focused on the relationship between T6SS and flagella-associated motility. Electron microscopy revealed the absence of flagellar filaments for MFE01Δhcp1 and MFE01ΔtssC mutants. Transcriptomic analysis showed a reduction in the transcription of class IV flagellar genes in these T6SS mutants. However, transcription of fliA, the gene encoding the class IV flagellar sigma factor, was unaffected. Over-expression of fliA restored the motile and mucoid phenotypes in both MFE01Δhcp1+fliA, and MFE01ΔtssC+fliA and a fliA mutant displayed the same phenotypes as MFE01Δhcp1 and MFE01ΔtssC. Moreover, the FliA anti-sigma factor FlgM was not secreted in the T6SS mutants, and flgM over-expression reduced both motility and mucoidy. This study provides arguments to unravel the crosstalk between T6SS and motility.Entities:
Keywords: FlgM; FliA; Hcp1; Pseudomonas fluorescens MFE01; flagella; motility inhibition; type VI secretion system
Year: 2020 PMID: 32344878 PMCID: PMC7286023 DOI: 10.3390/microorganisms8050622
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Strains and plasmids.
| Strain or Plasmid | Relevant Characteristics | Reference/Source |
|---|---|---|
|
| ||
| MFE01 | Air isolate, RifR | [ |
| MFE01+pPSV35 | MFE01 with pPSV35 empty vector, GmR | [ |
| MFE01+ | MFE01 with pPSV35 carrying wild-type | This study |
| MFE01Δ | MFE01 with a in | [ |
| MFE01Δ | MFE01Δ | [ |
| MFE01Δ | MFE01 with pPSV35 carrying wild-type | [ |
| MFE01Δ | MFE01Δ | This study |
| MFE01Δ | MFE01Δ | This study |
| MFE01Δ | MFE01 with | [ |
| MFE01Δ | MFE01Δ | [ |
| MFE01Δ | MFE01Δ | [ |
| MFE01Δ | MFE01Δ | This study |
| MFE01Δ | MFE01 with early stop codon in | [ |
| MFE01Δ | MFE01Δ | This study |
| MFE01Δ | MFE01 with | [ |
| MFE01Δ | MFE01Δ | [ |
| MFE01Δ | MFE01 with in | This study |
| MFE01Δ | MFE01Δ | This study |
| MFE01Δ | MFE01Δ | This study |
| MFE01+pJN105 | MFE01 with pJN105 empty vector, GmR | This study |
| MFE01+ | MFE01 with pJN105 carrying wild-type | This study |
| MFE01- | MFE01 with 3’ | This study |
| MFE01Δ | MFE01Δ | This study |
| MFN1032 | Clinical isolate | [ |
| MFN1032+pJN105 | MFN1032 with pJN105 empty vector, GmR | This study |
| MFN1032+ | MFN1032 with pJN105 carrying wild-type | This study |
|
| ||
| S17.1 | RP4-2-Tc::Mu, | [ |
| Top10® | F- | ThermoFischer Scientific |
| Plasmids | ||
| pPSV35 | [ | |
| pAKE604 | Conjugative suicide vector, | [ |
| pJN105 | Arabinose-inducible expression plasmid, GmR | [ |
Oligonucleotides used in this study. The underlined sequences correspond to the flag sequence.
|
| |
| Muta1-fliA-F | ACACTGGCCGACGTTATC |
| Muta2-fliA-EcoRI-R | TAATAAGAATTCGTAAAGATTCATGCCACTGG |
| Muta3-fliA-EcoRI-F | TAATAAGAATTCCTGTTCAGTTTCGACGAC |
| Muta4-fliA-R | CTTCAGCAGTCACCATCAA |
| Muta1-3’flag-flgM | TGATCAGGTCATCACACTG |
| Muta2-3’flag-flgM | CTTGTCATCGTCATCTTTATAATCGCGCTGGGCTTCGAAGTTG |
| Muta3-3’flag-flgM | GATTATAAAGATGACGATGACAAGTAGGCTTTTGCCGGCGCCAG |
| Muta4-3’flag-flgM | TTCATGGAAGGTGATGATCA |
| Muta1-tssC-F | CTGAGACTCCAGTAGCCAAG |
| Muta4-tssC-R | ATGTCATTGAGATCGGGCAA |
|
| |
| fliA-EcoRI-F | TAATAAGAATTCGGCATCTGGAATTTTTCGT |
| fliA-XbaI-R | TAATAATCTAGATCCCCACACTGCCTTCA |
| flgM-EcoRI-F | TAATAAGAATTCTCCAAATTCCCAGAGGTTTT |
| flgM-XbaI-R | TAATAATCTAGAGTCGTTGATCAGTTGCAATA |
|
| |
| qRT-PCR-RecA-F | AAGGGTGCCGTAATGCGTAT |
| qRT-PCR-RecA-R | ATATCCAGACCCAGAGAGCCAGTA |
| qRT-PCR-FliA-F | CTGGTGTTGGCGCTGTACTAC |
| qRT-PCR-FliA-R | GCCAAGGACTTCACCGATTT |
| qRT-PCR-FlgM-F | GTACCAGCAACGCCAAGGAA |
| qRT-PCR-FlgM-R | TGTACCGACTCCCCGCTTT |
| qRT-PCR-FleQ-F | CATCGCGAACCCAATCTGT |
| qRT-PCR-FleQ-R | GGCCACTTGCTGCATCATCT |
| qRT-PCR-RpoN-F | ACTGGTCGCAGCGGAAAAT |
| qRT-PCR-RpoN-R | ATGCCTTGTGCCTCCAGTAAA |
| qRT-PCR-FliS-F | GATGTTAGCCCTTCGGCAGTAC |
| qRT-PCR-FliS-R | CACCTTCCATCAACATTTGCA |
| qRT-PCR-FlaA-F | ACACCCAGGCCATCCAGAA |
| qRT-PCR-FlaA-R | TGCAGGATGTCGGTCGAA |
| qRT-PCR-MotA-F | GCGTTCGTCTGCGATTACCT |
| qRT-PCR-MotA-R | CGTGCGGAGCCATGTTG |
Figure 1Swimming motility and mucoidy of P. fluorescens MFE01 and mutants. (A) “Swimming motility”. Swimming assays were performed on 0.3% LB-agar, supplemented with 50 µg/mL gentamycin, overnight at 28 °C. EV: empty pPSV35 vector, +: motile, −: non-motile. The images shown are representative of three assays (n = 3). (B) Mucoid phenotype. Mucoidy was assessed on 1.5% LB agar, supplemented with 50 µg/mL gentamycin, after incubation for 24 h at 28 °C. EV: empty pPSV35 vector, +: mucoid, −: non-mucoid. The images shown are representative of three assays (n = 3).
Figure 2Flagella of P. fluorescens MFE01 and derivatives. Transmission electron microscopy images of bacteria grown at 28 °C (negative stain). All tested strains (MFE01, MFE01Δhcp1, MFE01Δhcp2, and MFE01Δhcp3) contained the empty pPSV35 vector. Arrows indicate a flagellum. These images are representative of at least 35 bacteria for each strain.
Figure 3Effect of fliA mutation on phenotypes of MFE01. (A) Swimming motility. Swimming assays were performed on 0.3% LB-agar for 24 h at 28 °C. +: motile, −: non-motile, ++: hyper-motile. EV: empty pPSV35. The images shown are representative of three assays (n = 3). (B) Hcp and flagellin secretion. Concentrated supernatants of cultures in the late exponential growth phase, grown at 28 °C, were analysed by SDS-PAGE (12% separation gel) and Coomassie staining. Bands indicated by the arrows and labelled H and F were identified by MALDI/ToF as Hcp and flagellin proteins, respectively. The periplasmic alkaline phosphatase of MFE01, used as control for cell lysis, was not detected in these experiments. MWM: molecular weight marker, EV: empty pPSV35 vector. (C) Mucoid phenotypes. Mucoidy was assessed on 1.5% LB-agar, supplemented with 50 µg/mL gentamycin, after incubation for 24 h at 28 °C. EV: empty pPSV35 vector, +: mucoid, −: non-mucoid. The images shown are representative of three assays (n = 3).
Figure 4Transcription of flagellar genes in MFE01 and derivatives. (A) Putative promoters upstream of flagellar genes. A consensus motif (TAAAGTTT-N11-GCCGATAA), corresponding to promoters recognised by FliA in Pseudomonas aruginosa [40], was used to search for putative FliA-dependent promoters upstream of flagellar genes in MFE01. Sequences corresponding to putative promoters are indicated. (B) MEME sequence logo of the four putative promoter motifs. The sequence logo, generated by Multiple Em for Motif Elicitation (MEME), corresponding to the putative FliA-dependent promoters, is shown. (C) Flagellar gene expression in MFE01ΔfliA+EV and MFE01ΔfliA+fliA. The reported mRNA levels are relative to those obtained in MFE01 carrying the empty pPSV35 vector. Relative levels of gene expression are based on the comparative CT (2–ΔΔCT) method, using MFE01 recA mRNA as endogenous control. Statistical analyses were performed using Non-parametric Mann–Whitney Tests (two tailed). A p-value < 0.05 was considered to be statistically significant. *P < 0.05, n = 6. Data shown represent the mean ± SEM. In this experiment, the primers used for fliA were located downstream of the fliA central in-frame deletion.
Figure 5Effect of introducing fliA on phenotypes in MFE01 and derivatives. (A) Impact of introducing fliA on the swimming motility of MFE01 and derivatives. Swimming assays were performed on 0.3% LB agar for 24 h at 28 °C. +: motile, −: non-motile, ++: hyper-motile, EV: empty pPSV35 vector. The images shown are representative of three assays (n = 3). (B) Mucoid phenotypes after introducing fliA into MFE01 and derivatives. Mucoidy was assessed on 1.5% LB agar, supplemented with 50 µg/mL gentamycin, after incubation for 24 h at 28 °C. EV: empty pPSV35 vector, +: mucoid, −: non-mucoid. The images shown are representative of three assays (n = 3). (C) Flagella of P. fluorescens MFE01 and derivatives after introducing fliA. Transmission electron microscopy images of bacteria grown at 28 °C (negative stain). MFE01ΔtssC contained the empty pPSV35 vector. Arrows indicate multiple flagella. These images are representative of at least 35 bacteria for each strain.
Figure 6Expression of flagellar genes in various MFE01 mutants. The mRNA levels shown are relative to those obtained in MFE01 carrying the empty pPSV35 vector. Relative levels of gene expression are based on the comparative CT (2−ΔΔCT) method, using MFE01 recA mRNA as endogenous control. Statistical analyses were performed using Non-parametric Mann–Whitney Tests (two tailed). A p-value < 0.05 was considered to be statistically significant. * p < 0.05, n = 6. Data shown represent the mean ± SEM.
Figure 7Localisation of FlgM::Flag in MFE01 or MFE01Δhcp1. (A) Western-blot analysis of protein fractions of MFE01-flgM::flag and MFE01Δhcp1-flgM::flag. An anti-Flag antibody coupled to alkaline phosphatase was used to visualise FlgM-Flag proteins. The images shown are representative of three assays (n = 3). The band at 50 kDa corresponds to MFE01 intracellular alkaline phosphatase. The band with a molecular weight < 15 kDa (dye front) corresponds to FlgM-Flag (11 kDa). (B) Western-blot analysis of concentrated intracellular protein fractions of MFE01- flgM::flag and MFE01Δhcp1-flgM::flag. An anti-Flag antibody coupled to alkaline phosphatase was used to visualise FlgM-Flag proteins. The images shown are representative of three assays (n = 3). The positive control is a non-concentrated intracellular fraction in which the band at 50 kDa corresponds to MFE01 periplasmic alkaline phosphatase. The band with a molecular weight < 15 kDa (dye front) corresponds to FlgM-Flag (11 kDa).
Figure 8Phenotypic effects of flgM overexpression in MFE01 and MFN1032. (A) Mucoid phenotype of MFE01+flgM. Mucoidy was assessed on 1.5% LB-agar, supplemented with 50 µg/mL gentamycin, after incubation for 24 h at 28 °C. EV: empty pJN105 vector, +: mucoid, −: non-mucoid. The images shown are representative of three assays (n = 3). (B) Swimming motility of MFE01+flgM. Swimming assays were performed on 0.3% LB-agar, supplemented with 1% arabinose and 50 mg/mL gentamycin at 28 °C. (n = 3). −: non-motile, +: motile, EV: empty pJN105 vector. The images shown are representative of three assays. C. Swimming motility of MFN1032+flgM. Swimming assays were performed on 0.3% LB-agar, supplemented with 1% arabinose and 50 mg/mL gentamycin at 28 °C. −: non-motile, +: motile. EV: empty pJN105 vector. The images shown are representative of three assays.